彭布罗利珠单抗
医学
佐剂
甲状腺间变性癌
肿瘤科
甲状腺癌
内科学
辅助治疗
阶段(地层学)
甲状腺
癌症
免疫疗法
生物
古生物学
作者
Maria E. Cabanillas,Naifa L. Busaidy,G. Brandon Gunn,Padmini Iyer,Renata Ferrarotto,Maria Gule-Monroe,Anastasios Maniakas,Michelle D. Williams,Suyu Liu,Bryan Fellman,Michael T. Spiotto,Sarah Hamidi,Neal S. Akhave,Anna Lee,Jennifer Wang,Luana Guimarães de Sousa,Vicente Rodrigues Marczyk,Mark Zafereo,Ramona Dadu,Vicente Rodrigues Marczyk
出处
期刊:Thyroid
[Mary Ann Liebert, Inc.]
日期:2025-07-01
卷期号:35 (7): 763-770
被引量:8
标识
DOI:10.1089/thy.2025.0194
摘要
Background: Anaplastic thyroid cancer (ATC) has historically been almost uniformly fatal. In patients with the loco-regional disease (stage IVB), multimodal therapy (upfront surgery when feasible, radiation +/- concurrent chemotherapy) followed by observation is the current standard of care.
科研通智能强力驱动
Strongly Powered by AbleSci AI